List of Maxcyte patents

Patents where

Current Assignee

Name

Maxcyte

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11331344 Engineering and delivery of therapeutic compositions of freshly isolated cells		Maxcyte	Maxcyte	United States Patent and Trademark Office	11331344	May 17, 2022
‌ US Patent 9669058 Engineering and delivery of therapeutic compositions of freshly isolated cells	Patent 9669058 was granted and assigned to Maxcyte on June, 2017 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	9669058	June 6, 2017
‌ US Patent 8450112 Engineering and delivery of therapeutic compositions of freshly isolated cells	Patent 8450112 was granted and assigned to Maxcyte on May, 2013 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	8450112	May 28, 2013
‌ US Patent 7141425 Apparatus and method for electroporation of biological samples	Patent 7141425 was granted and assigned to Maxcyte on November, 2006 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	7141425	November 28, 2006
‌ US Patent D1016816 Docking station	Patent D1016816 was granted and assigned to Maxcyte on March, 2024 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D1016816	March 5, 2024
‌ US Patent 11608511 Methods for modifying genomic DNA	Patent 11608511 was granted and assigned to Maxcyte on March, 2023 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	11608511	March 21, 2023
‌ US Patent 7029916 Apparatus and method for flow electroporation of biological samples	Patent 7029916 was granted and assigned to Maxcyte on April, 2006 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	7029916	April 18, 2006
‌ US Patent 7991559 Computerized electroporation	Patent 7991559 was granted and assigned to Maxcyte on August, 2011 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	7991559	August 2, 2011
‌ US Patent 7771984 Methods and devices related to a regulated flow electroporation chamber	Patent 7771984 was granted and assigned to Maxcyte on August, 2010 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	7771984	August 10, 2010
‌ US Patent 9546350 Methods and devices related to a regulated flow electroporation chamber	Patent 9546350 was granted and assigned to Maxcyte on January, 2017 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	9546350	January 17, 2017
‌ US Patent D965816 Electroporation device	Patent D965816 was granted and assigned to Maxcyte on October, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D965816	October 4, 2022
‌ US Patent D967126 Electroporation device screen with pattern	Patent D967126 was granted and assigned to Maxcyte on October, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D967126	October 18, 2022
‌ US Patent D942039 Electroporation device	Patent D942039 was granted and assigned to Maxcyte on January, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D942039	January 25, 2022
‌ US Patent D923199 Electroporation device	Patent D923199 was granted and assigned to Maxcyte on June, 2021 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D923199	June 22, 2021
‌ US Patent D942038 Electroporation device	Patent D942038 was granted and assigned to Maxcyte on January, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D942038	January 25, 2022
‌ US Patent D923200 Electroporation device	Patent D923200 was granted and assigned to Maxcyte on June, 2021 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D923200	June 22, 2021
‌ US Patent D942040 Electroporation device	Patent D942040 was granted and assigned to Maxcyte on January, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D942040	January 25, 2022
‌ US Patent D942041 Electroporation device	Patent D942041 was granted and assigned to Maxcyte on January, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D942041	January 25, 2022
‌ US Patent D943760 Electroporation processing assembly	Patent D943760 was granted and assigned to Maxcyte on February, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D943760	February 15, 2022
‌ US Patent D944410 Electroporation processing assembly	Patent D944410 was granted and assigned to Maxcyte on February, 2022 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D944410	February 22, 2022
‌ US Patent 10316335 Methods and compositions for generating stable transfected cells	Patent 10316335 was granted and assigned to Maxcyte on June, 2019 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	10316335	June 11, 2019
‌ US Patent 9132153 Engineering and delivery of therapeutic compositions of freshly isolated cells	Patent 9132153 was granted and assigned to Maxcyte on September, 2015 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	9132153	September 15, 2015
‌ US Patent 10660917 Engineering and delivery of therapeutic compositions of freshly isolated cells		Maxcyte	Maxcyte	United States Patent and Trademark Office	10660917	May 26, 2020
‌ US Patent 7186559 Apparatus and method for electroporation of biological samples	Patent 7186559 was granted and assigned to Maxcyte on March, 2007 by the United States Patent and Trademark Office.		Maxcyte	United States Patent and Trademark Office	7186559	March 6, 2007
‌ US Patent D1017609 Docking station	Patent D1017609 was granted and assigned to Maxcyte on March, 2024 by the United States Patent and Trademark Office.	Maxcyte	Maxcyte	United States Patent and Trademark Office	D1017609	March 12, 2024

Results per page:

25 results

0 selected

25 results

0 selected